Revenue in Q1 2026 increased 56% to $19.8 billion primarily driven by volume growth, partially offset by lower realized prices from Mounjaro and Zepbound. Q1 2026 EPS increased by 170% to $8.26 on a reported basis and increased by 156% to $8.55 on a non-GAAP basis. The Q1 2026 reported...
Hence then, the article about lilly reports first quarter 2026 financial results raises full year guidance and highlights momentum of new medicines was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines )
Also on site :
- Microsoft, Meta, and Google just announced billions more in AI spending. Only Google convinced investors it’s paying off
- Meta’s AI Is Delivering but Comes With a Hefty Price Tag .. PYMNTS.com
- 2026 Billboard Women in Music Red Carpet: The Best Photos